UCL researchers launch congenital muscular dystrophy research programme The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK Read More
Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine The SHIELD-Utah study compared Novavax’s vaccine to the Pfizer/BioNTech mRNA 2024-2025 vaccine Read More
FDA approves Click’s digital therapeutic for episodic migraine More than 37 million adults in the US are affected by migraine Read More